Table 2.

Pyrethroid active substances for which the residue definition is not (re)assessed

Fenvalerate	Not approved in the EU. EFSA conclusion not available. Esfenvalerate is an isomer of fenvalerate. The non‐isomeric common metabolites that could be formed from fenvalerate isomers could be assessed in the remit of the review of esfenvalerate.
Permethrin	Not approved in the EU. EFSA conclusion and MRL review not available. Peer‐reviewed residue definition not available. The residue definition only needs to be assessed should an application for an import tolerance be received.
Fenpropathrin	Not approved in the EU. EFSA conclusion and MRL review not available. Peer=reviewed residue definition not available. An assessment will be provided by EFSA in the remit of an ongoing Art. 43 mandate for the assessment of non‐approved active substances.
Cyfluthrin	Not approved in the EU. Based on the plant and livestock metabolism data available to EFSA, the common metabolites subject to this assessment are not formed.
Beta‐cyfluthrin	Not approved in the EU. Based on the plant and livestock metabolism data available to EFSA, the common metabolites subject to this assessment are not formed.
Acrinathrin	Not approved in the EU and no CXLs in place. The residue definition only needs to be assessed should an application for an import tolerance be received.